Recovery From Schizophrenia: Psychiatry And Political Economy

352 NOTES14 Bowers, M.B., “Central dopamine turnover in schizophrenic syndromes,” Archives ofGeneral Psychiatry, 31:50–4, 1974.15 Burt, D.R., Creese, I. and Snyder, S.H., “Antischizophrenic drugs: Chronictreatment elevates dopamine receptor binding in brain,” Science, 196:326–8, 1977;Muller, P. and Seeman, P., “Brain neurotransmitter receptors after long-termhaloperidol: Dopamine, acetylcholine, serotonin, -noradrenergic and naloxonereceptors,” Life Sciences, 21:1751–8, 1977; Abi-Dargham, “Increased striataldopamine transmission in schizophrenia;” Kapur, “Relationship between dopamineD 2 and side effects;” Kapur, “Does fast dissociation explain the action of atypicalantipsychotics?”16 Farde, “D 2 dopamine receptors in neuroleptic-naïve schizophrenic patients;” Kapur,“Dopamine D 2 receptors and their role in atypical antipsychotic action;” Kapur,“Relationship between dopamine D 2 and side effects.”17 Rosen, B., Engelhardt, D.M., Freedman, N. et al, “The hospitalization pronenessscale as a predictor of response to phenothiazine treatment. I: Prevention ofpsychiatric hospitalization,” Journal of Nervous and Mental Disease, 146:476–80, 1968.18 Rosen B., Engelhardt, D.M., Freedman, N. et al, “The hospital proneness scale as apredictor of response to phenothiazine treatment. II: Delay of psychiatrichospitalization,” Journal of Nervous and Mental Disease, 152:405–11, 1971.19 Goldstein, M.J., “Premorbid adjustment, paranoid status, and patterns of response tophenothiazine in acute schizophrenia,” Schizophrenia Bulletin, 3:24– 37,1970; Evans,J.R., Rodnick, E.H., Goldstein, M.J. and Judd, L.L., “Premorbid adjustment,phenothiazine treatment, and remission in acute schizophrenics,” Archives of GeneralPsychiatry, 27:486–90, 1972.20 Judd, L.L., Goldstein, M.J., Rodnick, E.H. and Jackson, N.L.P., “Phenothiazineeffects in good premorbid schizophrenics divided into paranoid non-paranoidstatus,” Archives of General Psychiatry, 29:207–11, 1973.21 Goldstein, M.J., Rodnick, E.H., Evans, J.R. et al., “Drug and family therapy in theaftercare of acute schizophrenics,” Archives of General Psychiatry, 35:1169–77, 1978.22 Rappaport, M., Hopkins, H.K., Hall, K. et al. “Are there schizophrenics for whomdrugs may be unnecessary or contraindicated?’ International Pharmacopsychiatry, 13:100–11, 1978, p. 107.23 Carpenter, W.T., McGlashan, T.H. and Strauss, J.S., “The treatment of acuteschizophrenia without drugs: An investigation of some current assumptions,”American Journal of Psychiatry, 134:14–20, 1977, p. 19.24 Klein, D.G. and Rosen, B., “Premorbid asocial adjustment and response tophenothiazine treatment among schizophrenic inpatients,” Archives of GeneralPsychiatry, 29:480–5, 1973.25 May, P.R.A., Tuma, A.H. and Dixon, W.J., “Schizophrenia—A follow-up study ofresults of treatment. I: Design and other problems,” Archives of General Psychiatry, 33:474–8, 1976; May, P.R.A., Tuma, A.H. and Dixon, W.J., “Schizophrenia: Afollow-up study of the results of five forms of treatment,” Archives of GeneralPsychiatry, 38:776–84, 1981.26 Schooler, N.R., Goldberg, S.C., Boothe, H. and Cole, J.O., “One year afterdischarge: Community adjustment of schizophrenic patients,” American Journal ofPsychiatry, 123:986–95, 1967.